Navigation

NEWS RELEASES

Search all of our news releases here.

Search
Generic filters

Try these: Jeff GalvinHIVFDAAmerican Gene Technologies

American Gene Technologies Gains Additional Immuno-Oncology Patent

Mar 19, 2018

Novel approach to activating gamma delta T cells shows promise in animal studies — demonstrating efficacy in multiple epithelial solid tumors and metastases ROCKVILLE, Md., March 19, 2018 (GLOBE NEWSWIRE) — American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced… [Read More]

American Gene Technologies Announces Progress toward Phase I Clinical Trial of AGT103-T for HIV cure

Jan 29, 2018

Completes process development for the AGT103-T automated cell manufacturing protocol ROCKVILLE, MD, January 25, 2018 — American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced completion of the pilot runs of its HIV cure automated cell processing protocol. This completes… [Read More]

American Gene Technologies Receives U.S. Patent on Novel Immuno-Oncology Methods of Treating Cancer through Activation of Gamma Delta T Cells

Dec 12, 2017

Patent encompasses AGT’s advanced gene and cell therapy strategy for oncology ROCKVILLE, MD, December 12, 2017 — American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced the issuance of U.S. Patent No: 9,834,790 dated December 5, 2017, covering methods of… [Read More]

AGT CSO, David Pauza, to Present HIV cure data At The Cell & Gene Meeting on the Mesa

Sep 29, 2017

ROCKVILLE, MD., September. 26, 2017 (GLOBE NEWSWIRE) — American Gene Technologies International Inc. (AGT), a gene technology company focusing on a lentiviral delivery platform, today announced that Chief Science Officer C. David Pauza, Ph.D., will present at the upcoming Cell & Gene Meeting on the Mesa… [Read More]

AGT Builds Montgomery County Gene & Cell Therapy Momentum

Sep 25, 2017

Fast Growing Maryland Biotech Company Moves to a 24,000 Sq. Ft. Location and Will Host Ribbon Cutting Ceremony on October 23, 2017. September 25, 2017. Montgomery County, MD: American Gene Technologies (AGT), a private Maryland biotechnology company developing cures and treatments for Infectious diseases, cancers and monogenic disorders,… [Read More]

American Gene Technologies Inc. Appoints Julia R. Brown to its Board of Directors

Sep 11, 2017

ROCKVILLE, Md., Sept. 11, 2017 (GLOBE NEWSWIRE) — American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company with a broad and robust lentiviral drug-development platform, today announced the appointment of Julia R. Brown to its board of directors. Jeffrey A. Galvin… [Read More]

AGT’s CEO to Present at the 2017 BIO International Convention

Jun 7, 2017

  ROCKVILLE, MD, June 07, 2017 American Gene Technologies International Inc. (AGT), a genetic medicine company with a broad, robust lentiviral delivery platform, announced today that its CEO, Jeff Galvin, is presenting at the upcoming BIO International Convention. The Convention is being held on June… [Read More]

AGT CEO, Jeff Galvin, to Present at HIMSS Precision Medicine Summit

May 31, 2017

ROCKVILLE, MD, May 31, 2017 — American Gene Technologies International Inc. (AGT), a gene technology company with a broad and robust lentiviral delivery platform, today announced that Jeff Galvin, CEO, will present at the upcoming Health Information Management System Society (HIMSS) Precision Medicine Summit, being… [Read More]

American Gene Technologies Announces Appointment of C. Neil Lyons as Chief Financial Officer

Apr 12, 2017

Rockville, Maryland, April 12, 2017 American Gene Technologies International Inc. (AGT), a genetic drug development company, announced the appointment of C. Neil Lyons as Executive Vice President and Chief Financial Officer.   Mr. Lyons joins AGT with over a decade of experience leading finance for clinical-stage,… [Read More]

American Gene Technologies Announces Collaboration with GeoVax for HIV cure

Mar 14, 2017

Clinical Trial Expected to Commence in 2017   Rockville, MD, March 14, 2017 American Gene Technologies International Inc. (“AGT“) – announced today its collaboration with GeoVax Labs, Inc. (OTCQB: GOVX) for the conduct of a Phase 1 clinical trial investigating AGT’s viral vector technology as a functional… [Read More]

Subscribe to News Releases and News Updates

Subscribe to our news release and published article updates to be notified when we release new content!

Follow AGT on Social Media